Mifobate
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-100277-1 mg |
| CAS # | 76541-72-5 |
| Pricing | 1 mg, USD $120.0 |
| Synonyms | SR-202 |
| MWt | 358.65 |
| Formula | C₁₁H₁₇ClO₇P₂ |
| Biological Activity | Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects[1]. |
| Purity | ≥99.0% |